Entreprise québécoise en TI qui se spécialise dans le développement d'un dossier médical élect
Location: Canada, Quebec, Cookshire-Eaton
Employees: 51-200
Founded date: 1984
Mentions in press and media 4
| Date | Title | Description |
| 27.07.2026 | Transcripta Bio Secures $24 Million to Accelerate AI Drug Discovery for Neurological Diseases | Transcripta Bio announced a significant $24 million capital raise. This funding, secured since its Series A, propels the company's AI-driven drug discovery platform. The Palo Alto firm targets neurological and neuromuscular diseases. New ca... |
| 22.07.2026 | Transcripta Bio Raises $24 Million To Advance AI-Powered Neurological Drug Pipeline | Transcripta Bio has raised $24 million since its Series A financing to advance an AI-powered drug discovery platform focused on neurological and neuromuscular diseases. New investors Mayo Clinic and Omnimed joined existing backers JAZZ Vent... |
| 22.07.2026 | Transcripta Bio Announces $24 Million Funding | PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A. >> Click here for more funding data on Transcripta Bio &... |
| - | Omnimed.Com | “Omnimed | Electronic medical record” |